Vertex Pharmaceuticals (VRTX) Current Leases (2012 - 2018)

Vertex Pharmaceuticals' Current Leases history runs 7 years deep, the most recent figure standing at $9.8 million for Q4 2018.

• In Q4 2018, Current Leases fell 56.43% year-over-year to $9.8 million; the TTM figure through Dec 2018 stood at $9.8 million (down 56.43% YoY), while the FY2018 annual figure was $9.8 million, down 56.43% from the prior year.
• Current Leases was $9.8 million for Q4 2018 at Vertex Pharmaceuticals, down from $11.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $22.5 million in Q4 2017 to a low of $9.8 million in Q4 2018.
• Historically, Current Leases has averaged $17.1 million across 5 years, with a median of $17.8 million in 2014.
• The sharpest annual moves came in 2014 and 2018: Current Leases surged 120.71% in 2014, then plunged 56.43% in 2018.
• A 5-year view of Current Leases shows it stood at $17.8 million in 2014, then decreased by 12.7% to $15.5 million in 2015, then rose by 24.97% to $19.4 million in 2016, then grew by 15.98% to $22.5 million in 2017, then slumped by 56.43% to $9.8 million in 2018.
• The last three Current Leases figures came in at $9.8 million (Q4 2018), $11.5 million (Q3 2018), and $15.1 million (Q2 2018), per Business Quant data.